Loading...
Helmerich and Payne Inc (HP) is not a strong buy at the moment for a beginner investor with a long-term strategy. Despite positive revenue growth, the company's financial performance is weak, with significant declines in net income, EPS, and gross margin. Technical indicators are mixed, with bearish MACD and RSI near neutral, though moving averages remain bullish. Options data suggests low put-call ratios, indicating a lack of bearish sentiment, but hedge funds are selling heavily. Analyst ratings are neutral to positive, but the stock lacks strong momentum or clear catalysts for immediate growth. Given the user's impatience and preference for long-term investments, holding off on buying HP is recommended until financial performance improves or stronger signals emerge.
The MACD is bearish with a histogram of -0.23, indicating downward momentum. RSI is neutral at 34.989, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support is at 32.649, with resistance at 36.308. The stock is trading near support levels, but no clear reversal signals are present.

Analysts have raised price targets recently, with some maintaining positive or overweight ratings. Moving averages remain bullish.
Net income dropped by -279.89% YoY, EPS fell by -281.48%, and gross margin declined by -51.39%. Hedge funds are selling heavily, with a 5577.59% increase in selling activity last quarter. MACD indicates bearish momentum, and RSI is near oversold territory. No recent news or congress trading data to support a positive sentiment shift.
In Q1 2026, revenue increased significantly by 50.16% YoY, but net income dropped to -$97.16M (-279.89% YoY). EPS fell to -0.98 (-281.48% YoY), and gross margin declined to 11.91 (-51.39% YoY). The company's profitability metrics are weak, despite revenue growth.
Analysts have raised price targets, with the majority maintaining neutral or positive ratings. Recent upgrades include targets of $38-$40, but concerns remain about near-term rig count weakness and international reactivation expenses. Analysts are cautiously optimistic about long-term prospects but note challenges in the short term.